Physician
Pathology
Dr. Dario Campana, MD
|
|
Give Review
Doctor Dario Campana, MD is an expert in the field of Pathology. Dario Campana is also a published doctor. He has 22 publication published. The most recent publication is: Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study.
Publications
- Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood Acute lymphoblastic leukaemia: a prospective study.
- Prognostic factors in children with Acute myeloid leukaemia and excellent response to remission induction therapy.
- Definition of cure in childhood Acute myeloid leukemia.
- A revised definition for cure of childhood Acute lymphoblastic leukemia.
- Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive Acute lymphoblastic leukemia.
- RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and Acute myeloid leukemia patients.
- Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood Acute myeloid leukemia.
- Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
- Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood Acute lymphoblastic leukemia.
- Prognostic features in Acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group S...
- Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for Acute lymphoblastic leukemia.
- Deep-sequencing approach for minimal residual disease detection in Acute lymphoblastic leukemia.
- Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia.
- Treatment outcome in older patients with childhood Acute myeloid leukemia.
- Effect of body mass index on the outcome of children with Acute myeloid leukemia.
- Combination of cladribine and cytarabine is effective for childhood Acute myeloid leukemia: results of the St Jude AML97 trial.
- Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
- Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.
- Early T-cell precursor leukaemia: a subtype of very high-risk Acute lymphoblastic leukaemia.
- Genome-wide interrogation of germline genetic variation associated with treatment response in childhood Acute lymphoblastic leukemia.
- Deletion of IKZF1 and prognosis in Acute lymphoblastic leukemia.
Conditions Treated
- Acute Leukemia
- Anemia
- Neutropenia
Doctors Specialties
- Oncology
- Pathology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Susan C. Goodman, MD |
|
|
Dr. Cameila D. Johns, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall T. Hayden, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mondira Kundu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrzej T. Slominski, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Antonio Martinez, MD |
|
|
Dr. Megan H. Kempe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gordon G. Wang, MD |